Evidence map›Paper›PMID 30680319›Full record

ArticleBioengineering & translational medicine2019

Multivariate learning framework for long-term adaptation in the artificial pancreas.

Dawei Shi, Eyal Dassau, Francis J Doyle

Open access · goldAbstract read
In one paragraph

Article in Bioengineering & translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Materials and System Design for Self-Decision Bioelectronic Systems.Advanced materials (Deerfield Beach, Fla.) · 2026
    Review
  3. Article
  4. Artificial Pancreas: The First 20 Years.Journal of diabetes science and technology · 2025
    Article
  5. APL bioengineering · 2023
    Article
  6. Review
  7. Article
  8. Bioengineering & translational medicine · 2020
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dawei ShiHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University Cambridge MA 02138.
Eyal DassauHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University Cambridge MA 02138.
Francis J DoyleHarvard John A. Paulson School of Engineering and Applied Sciences, Harvard University Cambridge MA 02138.
Harvard University · USHarvard University Press · US

Funding

Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) TrialUC4DK108483 · NIDDK · UNIVERSITY OF VIRGINIA · PI ANDERSON, STACEY, DOYLE, FRANCIS J · 2016 to 2016
$12.7M
Pediatric Artificial Pancreas System for Enhanced Diabetes Management in Young Children with Type 1 DiabetesDP3DK104057 · NIDDK · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI DASSAU, EYAL, DOYLE, FRANCIS J · 2014 to 2014
$1.8M
NIDDK NIH HHS DP3 DK104057NIDDK NIH HHS UC4 DK108483
6 · The paper itself

Abstract

The long-term use of the artificial pancreas (AP) requires an automated insulin delivery algorithm that can learn and adapt with the growth, development, and lifestyle changes of patients. In this work, we introduce a data-driven AP adaptation method for improved glucose management in a home environment. A two-phase Bayesian optimization assisted parameter learning algorithm is proposed to adapt basal and carbohydrate-ratio profile, and key feedback control parameters. The method is evaluated on the basis of the 111-adult cohort of the FDA-accepted UVA/Padova type 1 diabetes mellitus simulator through three scenarios with lifestyle disturbances and incorrect initial parameters. For all the scenarios, the proposed method is able to robustly adapt AP parameters for improved glycemic regulation performance in terms of percent time in the euglycemic range [70, 180] mg/dl without causing risk of hypoglycemia in terms of percent time below 70 mg/dl.

Indexed as

artificial pancreasdata‐driven algorithmsparameter adaptationsafety‐critical control

Identifiers

PMID30680319
PMCPMC6336673
OpenAlexW2899071799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.